Middleborough, MA, United States of America

Christopher O'Reilly

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Organogenesis, Inc.. Active years: 2004.



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Christopher O'Reilly

Introduction

Christopher O'Reilly is an accomplished inventor based in Middleborough, MA (US). He has made significant contributions to the field of biotechnology, particularly through his innovative designs in bioreactor systems. His work has the potential to enhance various applications in cell culture and tissue engineering.

Latest Patents

O'Reilly holds a patent for a culture dish and bioreactor system. This invention features a bioreactor with a base for defining a well, a dish with a membrane suspended in the base, and a lid equipped with gas-permeable membranes and self-sealing ports. This design aims to improve the efficiency and effectiveness of bioprocessing.

Career Highlights

Christopher O'Reilly is currently employed at Organogenesis, Inc., a company known for its advancements in regenerative medicine. His role at the company allows him to apply his innovative ideas in a practical setting, contributing to the development of cutting-edge medical solutions.

Collaborations

O'Reilly has collaborated with notable colleagues, including Leon M. Wilkins and Eric J. Roos. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of new technologies.

Conclusion

Christopher O'Reilly's contributions to the field of biotechnology through his patent and work at Organogenesis, Inc. highlight his role as an influential inventor. His innovative spirit continues to drive advancements in bioreactor systems, paving the way for future developments in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…